The new law bans the use of AI for mental health and therapeutic decision-making, but states it can be used for ...

Global healthcare venture fund OrbiMed announced it raised $1.86 billion for Healthcare Royalty and Credit Fund V to invest in growth-oriented companies.

The company will use the funds to scale its reach within the U.S and to expand access to its offerings globally.

The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second quarter earnings.

The company aims to help providers secure stable pricing and access products and services for patients seeking reproductive and sexual healthcare.

Clinicians need to have integrity with how they present AI tools to their teams, focusing on how those tools can solve problems, says Josh Wymer, chief health information and data strategy officer at ...